South Africa And Europe Poct Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 8,565.13 Million |
 시장 규모(예측 연도) |
USD 17,289.45 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
남아프리카 및 유럽 Point-of-Care-Testing(POCT) 시장, 제품 유형별(포도당 모니터링 제품, 감염성 질환 테스트 제품, 심장대사 모니터링 제품, 임신 및 생식 능력 테스트 제품, 혈액학 테스트 제품, 응고 모니터링 제품, 약물 남용(DOA) 테스트 제품, 요분석 테스트 제품, 콜레스테롤 테스트 제품, 종양/암 마커 테스트 제품, 분변 잠복 테스트 제품 및 기타), 응용 분야(혈당, 심장 모니터링, 혈액학 응고, 전혈 분석, 생체 신호 모니터링, 비침습적 Spo2 모니터링, 비침습적 Pco2 모니터링, 혈액 수혈 및 기타), 처방 모드(처방 기반 테스트 및 일반 의약품 테스트), 플랫폼(측면 흐름 분석/면역 크로마토그래피 테스트, 딥스틱, 분자 진단 , 면역 분석, 미세 유체 역학 , 임상 화학 분석) 혈액학 및 기타), 최종 사용자(진료소, 재택 치료, 병원, 실험실, 외래 수술 센터 및 기타), 유통 채널(직접 입찰, 소매 판매, 온라인 판매 및 기타) - 업계 동향 및 2030년까지의 예측.
남아프리카 및 유럽 Point-of-Care-Testing(POCT) 시장 분석 및 통찰력
남아프리카와 유럽의 진료소 검사(POCT) 시장 성장을 주도하는 주요 요인 중 하나는 다양한 만성 및 감염성 질환의 유병률 증가입니다. 진료소 검사 제품에 대한 인식이 높아짐에 따라 시장이 확대되고 있습니다. 시장은 또한 시장 참여자 간의 치열한 경쟁의 영향을 받습니다. 그러나 POCT 제품과 관련된 높은 비용은 예측 기간 동안 시장을 제한하는 요인으로 작용할 수 있습니다.
반면, 인지도 상승과 정부 자금 지원은 시장 성장의 기회로 작용합니다. 그러나 실험실에서 얻은 검사 결과와의 일치성 부족은 남아프리카와 유럽의 진료소 검사(POCT) 시장에 어려움을 초래할 수 있습니다.
남아프리카와 유럽의 진료 시점 검사(POCT) 시장은 2023년부터 2030년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2023년부터 2030년까지의 예측 기간 동안 9.3%의 CAGR로 성장하고 있으며 2022년의 8,565.13백만 달러에서 2030년까지 17,289.45백만 달러에 도달할 것으로 분석합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 맞춤형 (2015-2020) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
제품 유형(포도당 모니터링 제품, 감염성 질환 검사 제품, 심장대사 모니터링 제품, 임신 및 생식 능력 검사 제품, 혈액학 검사 제품, 응고 모니터링 제품, 약물 남용(DOA) 검사 제품, 요분석 검사 제품, 콜레스테롤 검사 제품, 종양/암 마커 검사 제품, 분변 잠복 검사 제품 및 기타), 응용 분야(혈당, 심장 모니터링, 혈액학 응고, 전혈 분석, 생체 신호 모니터링, 비침습적 Spo2 모니터링, 비침습적 Pco2 모니터링, 혈액 수혈 및 기타), 처방 모드(처방 기반 검사 및 일반 의약품 검사), 플랫폼(측면 흐름 검사/면역 크로마토그래피 검사, 딥스틱, 분자 진단, 면역 검사, 미세 유체 역학, 임상 화학 검사, 혈액학 및 기타), 최종 사용자(클리닉, 홈 케어, 병원, 실험실, 외래 수술 센터 등), 유통 채널(직접 입찰, 소매 판매, 온라인 판매 등) |
|
적용 국가 |
남아프리카공화국, 독일, 프랑스, 영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에, 그리고 유럽의 다른 지역. |
|
시장 참여자 포함 |
F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Werfen, Sysmex Europe SE., Danaher, Quidel Corporation, LumiraDx, BD, Abbott, Nova Biomedical, Abaxis, Trividia Health, Inc., Sekisui Diagnostics, Thermo Fisher Scientific Inc., EKF Diagnostics, Trinity Biotech, Chembio Diagnostics, Inc., PTS Diagnostics, binx health, inc., QuantuMDx Group Ltd. 등이 있습니다. |
시장 정의
진료소 검사(POCT) 시장은 환자의 위치 또는 그 근처에서 수행되는 진단 검사 시장을 말하며, 임상적 의사 결정을 위한 즉각적인 결과를 제공합니다. POCT는 전통적인 실험실 환경 밖에서, 일반적으로 병원, 진료소, 외래 진료 센터, 의사 사무실, 심지어 환자의 집과 같은 환경에서 의료 검사를 수행하는 것을 포함합니다. POCT는 진단 정보에 대한 빠르고 편리한 액세스를 제공하도록 설계되어 의료 전문가가 즉각적인 치료 결정을 내리고, 환자의 상태를 모니터링하고, 전반적인 환자 치료를 개선할 수 있도록 합니다. POCT에서 수행되는 검사는 감염성 질환, 심혈관 건강, 당뇨병 관리, 임신 및 생식, 종양학, 혈액학을 포함한 광범위한 의학 분야를 포괄합니다.
진료 시점 검사(POCT) 시장 동향
이 섹션에서는 시장 동인, 이점, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 감염성 및 만성 질환의 유병률 증가
암, 당뇨, 심혈관 질환과 같은 감염성 및 만성 질환의 유병률은 유럽 전역에서 빠르게 증가하고 있습니다. 세계보건기구(WHO)에 따르면 만성 질환의 기여도는 사망자 수를 차지하는 약 60%였습니다. 유럽에서 만성 질환이 증가하는 주요 이유는 노인 인구의 지속적인 증가입니다. 이러한 질병률 증가는 거의 모든 질병의 진단에 사용되기 때문에 POCT의 성장과 직접 비례합니다.
따라서 만성 질환의 유병률이 크게 증가하면 POCT 기기가 질병을 효과적으로 관리하고 필요할 때마다 모니터링하여 더 나은 편안함과 치료를 제공할 수 있으므로 시장 성장의 주요 동인이 될 것입니다.
- 개선된 진단 탐색 비율
의료 전문가의 역량 향상과 검사를 실시하는 전문가를 위한 정기적인 교육 세션이 해당 지역의 진단율 개선에 기여했으며, 암, 심혈관 질환, 제2형 당뇨병 등 만성 질환의 성공적인 진단이 증가했습니다.
관리 범위, 전문가가 진단에 사용한 시간, POCT 프로세스를 지원하기 위한 평가 활동을 포함하는 방법론이 도입되어 정보의 정확도를 개선하고 진단 측면에서 더 나은 의사 결정을 내리는 데 도움이 될 것입니다. 따라서 의료 및 IT 전문가의 노력, 의료 전문가의 교육 개선, 환자 치료 제공 시스템의 변화, 이 지역의 진단 추구율 개선이 시장 성장으로 이어지고 있습니다.
- 착용형 또는 휴대용 포도당 모니터링 장치에 대한 수요
요즘 당뇨병 환자가 늘어나면서 혈당 측정기는 포도당 수치를 측정하는 데 도움이 되므로 생존에 필수적이 되고 있습니다. POCT는 준수하기 쉬운 방식으로 환자에게 편안함을 제공하여 장치를 통해 건강 상태를 감지할 수 있으므로 원치 않는 건강 문제를 예방하는 데 도움이 됩니다.
따라서 착용형 및 휴대용 혈당 측정을 위한 새로운 케어 기기의 출시가 시장 성장을 견인할 것입니다.
기회
-
시장 참여자들의 전략적 이니셔티브
유럽에서 만성 및 감염성 질환의 유병률이 증가함에 따라 노인 인구 증가로 인해 효능이 개선되고 사이클 시간이 단축된 새롭고 진보된 POCT 키트와 솔루션이 필요하며, 또한 양질의 성과를 위한 의료 관리 및 진단을 개선해야 합니다. 주요 시장 리더는 의료 전문가의 요구를 충족시키고 더 나은 제품, 키트 및 시약을 생산하기 위해 연구에 시간을 투자하고 있습니다.
예를 들어,
-
2020년 5월, 로슈는 시퀀싱 기술 산업의 초기 단계에 있는 신생 기업인 스트라토스 제노믹스를 인수하여 빠르고 적응 가능하며 저렴한 임상 진단 테스트를 위해 DNA를 시퀀싱하는 전자 및 생물학적 구성 요소를 결합하는 나노포어 시퀀서 개발을 진행했습니다.
따라서 시장 참여자들의 이러한 전략적 이니셔티브는 시장 성장을 촉진하는 기회로 작용하고 있습니다.
-
인식 증가 및 정부 자금 지원
정부, 연방 및 시장의 주요 참여자는 개발도상국 사회에 인식을 확산하는 데 참여하고 있습니다. 참여자와 정부의 이러한 이니셔티브는 사용자가 저소득 및 개발도상국을 위해 만들어진 정책을 활용하고 조기에 진단하면 예방할 수 있는 질병을 인식하도록 돕고 있습니다. 병원 및 응급실에서 POCT의 성장은 정부 이니셔티브와 시간에 민감한 의학적 질병의 유행으로 인해 이미 강력하게 장려되고 있습니다.
제약/도전
- POCT 제품의 정확성 부족
POCT의 정확도는 검사 자체의 품질에 따라 달라집니다. 일부 POCT 기기는 실험실 기반 검사에 비해 민감도나 특이도가 낮을 수 있습니다. 정확한 결과를 보장하려면 고품질의 검증된 POCT 기기를 사용하는 것이 중요합니다. 일부 의학적 상태나 특정 검사는 실험실에서 수행하든 치료 시점에서 수행하든 정확도 측면에서 고유한 한계가 있을 수 있습니다. 특정 POCT 기기나 검사와 관련된 한계와 잠재적 오류 소스를 알고 있는 것이 중요합니다. POCT 분야에서 사전 분석 오류는 매우 흔합니다. 결과적으로 이러한 상황은 신제품 개발을 제한하여 시장 확장을 방해하고 제품 리콜로 이어지며 영구적인 철수를 위해 수행됩니다.
- POCT 제품 의 높은 비용
검사 장치, 카트리지, 일회용품을 포함한 POCT 제품의 높은 비용은 의료 서비스 제공자, 특히 소규모 진료소와 시설이 POCT 프로그램을 도입하고 구현하는 데 재정적으로 어려움을 겪을 수 있습니다. 필요한 장비를 구매하고 소모품 공급을 유지하는 데 필요한 사전 투자는 상당한 장벽이 될 수 있습니다. POCT 제품의 높은 비용은 간접적으로 환자에게도 영향을 미칠 수 있습니다. POCT 비용이 환자에게 전가되면 일부 개인, 특히 보험에 가입하지 않았거나 공제금이 높은 개인이 검사를 받을 수 없게 될 수 있습니다. 이는 환자가 대체 검사 방법을 선택하거나 검사를 전혀 하지 않을 수 있으므로 POCT의 도입 및 활용을 방해할 수 있습니다.
최근 개발 사항
- 2022년 4월, Sysmex Europe SE는 뮌헨에서 열린 제24회 IFCC-EFLM 유럽 임상화학 및 검사의학 대회에서 진료 시점 검사 기기를 출시했습니다. 이 제품 출시로 인해 POCT 기기의 레버리지와 유통을 위한 시장 참여자와의 파트너십이 증가하고 제품 포트폴리오에 새로운 제품이 추가되어 수익이 증가했습니다.
- 2021년 4월, Danaher는 새로운 기술 개발을 지원하고 Danaher에 영향을 미치는 빠르게 부상하는 과학 및 기술 트렌드에 고유한 관점을 제공하기 위해 유명 과학자들이 새로운 과학 자문 위원회에 합류한다고 발표했습니다. 이를 통해 회사는 세그먼트 포트폴리오를 다각화하는 데 도움이 되었습니다.
남아프리카 및 유럽 Point-of-Care-Testing(POCT) 시장 범위
남아프리카와 유럽의 진료 시점 검사(POCT) 시장은 제품 유형, 응용 프로그램, 처방 모드, 플랫폼, 최종 사용자 및 유통 채널을 기준으로 6개의 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
제품 유형
- 포도당 모니터링 제품
- 감염병 검사 제품
- 심장대사 모니터링 제품
- 임신 및 생식력 검사 제품
- 혈액학 검사 제품
- 응고 모니터링 제품
- 약물 남용(DOA) 테스트 제품
- 요분석 검사 제품
- 콜레스테롤 검사 제품
- 종양/암 마커 검사 제품
- 분변잠복검사제품
- 기타
제품 유형을 기준으로, 남아프리카와 유럽의 진료소 검사(POCT) 시장은 포도당 모니터링 제품, 감염성 질환 검사 제품, 심장대사 모니터링 제품, 임신 및 생식 능력 검사 제품, 혈액학 검사 제품, 응고 모니터링 제품, 약물 남용(DOA) 검사 제품, 요분석 검사 제품, 콜레스테롤 검사 제품, 종양/암 표지자 검사 제품, 분변 잠복 검사 제품 등으로 구분됩니다.
애플리케이션
- 혈당
- 심장 모니터링
- 혈액학
- 응고
- 전혈 분석
- 생명 징후 모니터링
- 비침습적 Spo2 모니터링
- 비침습적 Pco2 모니터링
- 수혈
- 기타
응용 분야를 기준으로, 남아프리카와 유럽의 진료소 검사(POCT) 시장은 혈당, 심장 모니터링, 혈액학, 응고, 전혈 분석, 생체 신호 모니터링, 비침습적 Spo2 모니터링, 비침습적 Pco2 모니터링, 수혈 및 기타로 구분됩니다.
처방 모드
- 처방 기반 테스트
- 처방전 없이 구입 가능한 테스트
처방 방식을 기준으로, 남아프리카와 유럽의 진료소 검사(POCT) 시장은 처방 기반 검사와 일반 의약품 검사로 구분됩니다.
플랫폼
- 측면 흐름 분석/면역 크로마토그래피 테스트
- 딥스틱
- 분자진단
- 면역 검정법
- 마이크로유체학
- 임상화학 검정
- 혈액학
- 기타
플랫폼을 기준으로, 남아프리카와 유럽의 진료소 검사(POCT) 시장은 측면 흐름 검사/면역 크로마토그래피 검사, 딥스틱, 분자 진단, 면역 검정, 미세유체역학, 임상 화학 검사, 혈액학 및 기타로 세분화됩니다.
최종 사용자
- 클리닉
- 홈 케어
- 병원
- 실험실
- 외래 수술 센터
- 기타
최종 사용자를 기준으로 볼 때, 남아프리카와 유럽의 진료소 검사(POCT) 시장은 진료소, 가정 간병 시설, 병원, 실험실, 외래 수술 센터 및 기타로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
- 온라인 판매
- 기타
유통 채널을 기준으로 볼 때, 남아프리카와 유럽의 진료시점 검사(POCT) 시장은 직접 입찰, 소매 판매, 온라인 판매 및 기타로 구분됩니다.
Point-of-Care-Testing (POCT) 시장 지역 분석/통찰력
진료시점 검사(POCT) 시장을 분석하고, 국가, 제품 유형, 애플리케이션, 처방 모드, 플랫폼, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 보고서에서 다루는 국가는 남아프리카공화국, 독일, 프랑스, 영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에, 그리고 나머지 유럽 국가입니다.
독일은 POCT 제품에 대한 인지도가 높아지고 정부 자금 지원도 늘어나면서 예측 기간 동안 지역 시장을 주도할 것으로 예상됩니다.
방광암 진단에 대한 수요는 기술 발전으로 인해 증가할 것입니다. 다양한 회사가 시장 성장으로 점차 이어지는 이니셔티브를 취하고 있습니다.
경쟁 환경 및 진료 시점 검사(POCT) 시장 점유율 분석
진료 시점 검사(POCT) 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 회사가 시장에 집중하는 것과만 관련이 있습니다.
시장에서 활동하는 주요 기업으로는 F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Werfen, Sysmex Europe SE., Danaher, Quidel Corporation, LumiraDx, BD, Abbott, Nova Biomedical, Abaxis, Trividia Health, Inc., Sekisui Diagnostics, Thermo Fisher Scientific Inc., EKF Diagnostics, Trinity Biotech, Chembio Diagnostics, Inc., PTS Diagnostics, binx health, inc., QuantuMDx Group Ltd. 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 STRATEGIC INITIATIVES
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO IN EUROPE
5.2 REGULATORY SCENARIO IN SOUTH AFRICA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES
6.1.2 IMPROVED DIAGNOSIS-SEEKING RATE
6.1.3 DEMAND FOR WEARABLE OR PORTABLE GLUCOSE MONITORING DEVICES
6.1.4 RISING PREFERENCE FOR HOMECARE TESTING
6.2 RESTRAINTS
6.2.1 LACK OF ACCURACY WITH POCT PRODUCTS
6.2.2 HIGH COST OF POCT PRODUCT
6.2.3 LACK OF TRAINING
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.3.2 RISING AWARENESS AND GOVERNMENT FUNDING
6.4 CHALLENGES
6.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
6.4.2 IMPROPER CARE OF POCT DEVICES
7 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 GLUCOSE MONITORING PRODUCTS
7.2.1 STRIPS
7.2.2 METERS
7.2.3 LANCETS AND LANCING DEVICES
7.3 INFECTIOUS DISEASE TESTING PRODUCTS
7.3.1 INFLUENZA TESTING PRODUCTS
7.3.1.1 TRADITIONAL DIAGNOSTIC TEST
7.3.1.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
7.3.1.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
7.3.1.1.3 VIRAL CULTURE
7.3.1.1.4 SEROLOGICAL ASSAY
7.3.1.2 MOLECULAR DIAGNOSTIC ASSAY
7.3.1.2.1 RT-PCR
7.3.1.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
7.3.1.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
7.3.1.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
7.3.2 HIV TESTING PRODUCTS
7.3.2.1 TESTING EQUIPMENT
7.3.2.2 TESTING REAGENT
7.3.3 HEPATITIS C TESTING PRODUCTS
7.3.3.1 HCV ANTIBODY TESTS
7.3.3.2 HCV VIRAL LOAD TESTS
7.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
7.3.4.1 NAAT-BASED SYSTEMS
7.3.4.2 NON–NAAT-BASED SYSTEMS
7.3.5 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING
7.3.6 RESPIRATORY INFECTION TESTING PRODUCTS
7.3.7 TROPICAL DISEASE TESTING PRODUCTS
7.3.8 COVID 19
7.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
7.4 CARDIOMETABOLIC MONITORING PRODUCTS
7.4.1 CARDIAC MARKER TESTING PRODUCTS
7.4.1.1 HSTNL
7.4.1.2 BNP
7.4.1.3 D-DIMER
7.4.1.4 CK-MB
7.4.1.5 MYOGLOBIN
7.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
7.4.2.1 CARTRIDGES
7.4.2.2 REAGENTS
7.4.3 HBA1C TESTING PRODUCTS
7.4.3.1 HBA1C TESTING INSTRUMENTS
7.4.3.2 HBA1C TESTING CONSUMABLES
7.4.4 POC ANALYZER
7.4.5 ECG DEVICES
7.4.5.1 RESTING ECG DEVICES
7.4.5.2 STRESS ECG DEVICES
7.4.5.3 HOLTER MONITORS
7.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
7.5.1 PREGNANCY TESTING PRODUCTS
7.5.1.1 STRIPS/ DIP STICKS AND CARDS
7.5.1.2 MID STREAM DEVICES
7.5.1.3 CASSETTES
7.5.1.4 DIGITAL DEVICES
7.5.1.5 LINE-INDICATOR DEVICES
7.5.2 FERTILITY TESTING PRODUCTS
7.5.2.1 HUMAN CHORIONIC GONADOTROPIN (HCG) URINE TEST
7.5.2.2 FSH URINE TEST
7.5.2.3 LUTEINIZING HORMONE (LH) URINE TEST
7.6 HAEMATOLOGY TESTING PRODUCTS
7.7 COAGULATION MONITORING PRODUCTS
7.7.1 ANTICOAGULATION MONITORING DEVICES
7.7.2 PLATELET FUNCTION MONITORING DEVICES
7.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES
7.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS
7.8.1 DOA ANALYZERS
7.8.1.1 IMMUNOASSAYS
7.8.1.2 CHROMATOGRAPHIC DEVICES
7.8.1.3 BREATH ANALYZERS
7.8.2 RAPID TESTING DEVICES
7.8.2.1 URINE TESTING DEVICES
7.8.2.2 ORAL FLUID TESTING DEVICES
7.9 URINALYSIS TESTING PRODUCTS
7.9.1 POC URINE STRIP SELF-TESTING
7.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING
7.1 CHOLESTEROL TESTING PRODUCTS
7.10.1 INSTRUMENTS
7.10.1.1 TABLE-TOP ANALYZERS
7.10.1.2 HAND-HELD ANALYZERS
7.10.2 TESTING KITS
7.11 TUMOR/CANCER MARKER TESTING PRODUCTS
7.12 FECAL OCCULT TESTING PRODUCTS
7.12.1 GUAIAC FOB STOOL TEST
7.12.2 IMMUNO-FOB AGGLUTINATION TEST
7.12.3 LATERAL FLOW IMMUNO-FOB TEST
7.12.4 IMMUNO-FOB ELISA TEST
7.13 OTHERS
8 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BLOOD GLUCOSE
8.3 CARDIAC MONITORING
8.4 HAEMATOLOGY
8.5 COAGULATION
8.6 WHOLE BLOOD ANALYSIS
8.7 VITAL SIGN MONITORING
8.8 NON- INVASIVE SPO2 MONITORING
8.9 NON- INVASIVE PCO2 MONITORING
8.1 BLOOD TRANSFUSION
8.11 OTHERS
9 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OVER THE COUNTER TESTING
10 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM
10.1 OVERVIEW
10.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
10.3 DIPSTICKS
10.4 MOLECULAR DIAGNOSTICS
10.5 IMMUNOASSAYS
10.6 MICROFLUIDICS
10.7 CLINICAL CHEMISTRY ASSAY
10.8 HEMATOLOGY
10.9 OTHERS
11 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER
11.1 OVERVIEW
11.2 CLINICS
11.3 HOME CARE
11.4 HOSPITALS
11.5 LABORATORIES
11.6 AMBULATORY SURGERY CENTERS
11.7 OTHERS
12 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 ONLINE SALES
12.5 OTHERS
13 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 SPAIN
13.1.5 ITALY
13.1.6 RUSSIA
13.1.7 NETHERLANDS
13.1.8 SWITZERLAND
13.1.9 TURKEY
13.1.10 BELGIUM
13.1.11 REST OF EUROPE
13.2 SOUTH AFRICA
14 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
14.2 COMPANY SHARE ANALYSIS: SOUTH AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 F HOFFMANN-LA ROCHE LTD
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 SIEMENS HEALTHCARE GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 WERFEN
16.3.1 1.3.1 COMPANY SNAPSHOT
16.3.2 PRODUCT PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 SYSMEX EUROPE SE.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 DANAHER
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 ABAXIS
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ABBOTT
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BD
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BINX HEALTH, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CHEMBIO DIAGNOSTICS SYSTEMS, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 EKF DIAGNOSTICS
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 LUMIRAXDX
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 NOVA BIOMEDICAL
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 PTS DIAGNOSTICS
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 QUANTUMDX GROUP LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 QUIDEL CORPORATION
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 SEKISUI DIAGNOSTICS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 THERMO FISHER SCIENTIFIC INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 TRINITY BIOTECH
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 TRIVIDIA HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 SOUTH AFRICA AND EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 3 SOUTH AFRICA AND EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 SOUTH AFRICA AND EUROPE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 SOUTH AFRICA AND EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 SOUTH AFRICA AND EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 SOUTH AFRICA AND EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 SOUTH AFRICA AND EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 SOUTH AFRICA AND EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 SOUTH AFRICA AND EUROPE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 SOUTH AFRICA AND EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 SOUTH AFRICA AND EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 SOUTH AFRICA AND EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 SOUTH AFRICA AND EUROPE ECG DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 SOUTH AFRICA AND EUROPE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 SOUTH AFRICA AND EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 SOUTH AFRICA AND EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 SOUTH AFRICA AND EUROPE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 SOUTH AFRICA AND EUROPE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 SOUTH AFRICA AND EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 SOUTH AFRICA AND EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 SOUTH AFRICA AND EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 SOUTH AFRICA AND EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 SOUTH AFRICA AND EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 SOUTH AFRICA AND EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 27 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 28 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 29 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 31 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 32 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 33 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 35 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 36 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 EUROPE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 38 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 39 EUROPE TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 40 EUROPE TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 41 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 43 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 44 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 46 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 47 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 49 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 52 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 53 EUROPE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 56 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 57 EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 59 EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 60 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 62 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 63 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 65 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 66 EUROPE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 69 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 72 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 73 EUROPE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 EUROPE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 75 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 77 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 80 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 81 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 83 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 84 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 86 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 87 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 88 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 90 EUROPE FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 92 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 93 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 94 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 95 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 96 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 99 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 100 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 GERMANY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 104 GERMANY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 105 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 106 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 107 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 108 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 110 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 111 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 113 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 114 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 116 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 117 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 120 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 123 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 124 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 126 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 127 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 128 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 129 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 130 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 133 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 134 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 136 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 137 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 141 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 142 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 144 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 145 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 147 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 148 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 151 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 152 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 154 GERMANY FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 157 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 158 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 163 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 164 U.K. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 U.K. INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 U.K. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 U.K. TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 168 U.K. TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 171 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 174 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 175 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 177 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 178 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 180 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 181 U.K. CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 184 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 185 U.K. BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 186 U.K. BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 187 U.K. BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 188 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 190 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 191 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 192 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 193 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 194 U.K. PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 197 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 198 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 200 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 201 U.K. COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 U.K. DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 203 U.K. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 U.K. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 205 U.K. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 206 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 208 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 209 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 210 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 211 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 212 U.K. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 215 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 216 U.K. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 U.K. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 218 U.K. FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 219 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 220 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 221 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 222 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 223 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 224 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 225 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 226 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 227 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 228 FRANCE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 FRANCE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 230 FRANCE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 231 FRANCE TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 232 FRANCE TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 233 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 234 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 235 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 236 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 238 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 239 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 241 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 242 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 244 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 245 FRANCE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 248 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 249 FRANCE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 250 FRANCE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 251 FRANCE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 252 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 254 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 255 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 257 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 258 FRANCE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 261 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 262 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 264 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 FRANCE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 FRANCE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 FRANCE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 FRANCE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 269 FRANCE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 270 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 272 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 273 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 275 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 276 FRANCE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 279 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 280 FRANCE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 FRANCE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 282 FRANCE FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 283 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 284 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 285 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 286 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 287 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 288 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 289 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 290 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 291 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 292 SPAIN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 293 SPAIN INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 294 SPAIN TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 SPAIN TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 296 SPAIN TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 297 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 298 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 299 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 300 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 301 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 302 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 303 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 304 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 305 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 306 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 307 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 308 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 309 SPAIN CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 311 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 312 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 313 SPAIN BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 SPAIN BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 315 SPAIN BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 316 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 318 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 319 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 320 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 321 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 322 SPAIN PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 323 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 325 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 326 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 328 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 329 SPAIN COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 SPAIN DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 SPAIN DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 SPAIN DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 333 SPAIN DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 334 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 335 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 336 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 337 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 339 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 340 SPAIN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 342 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 343 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 344 SPAIN FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 345 SPAIN FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 346 SPAIN FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 347 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 348 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 349 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 350 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 351 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 352 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 353 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 354 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 355 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 356 ITALY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 ITALY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 358 ITALY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 ITALY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 360 ITALY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 361 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 362 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 363 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 364 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 365 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 366 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 367 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 368 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 369 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 370 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 371 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 372 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 373 ITALY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 374 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 375 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 376 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 377 ITALY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 ITALY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 379 ITALY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 380 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 381 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 382 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 383 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 385 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 386 ITALY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 387 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 389 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 390 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 391 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 392 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 393 ITALY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 394 ITALY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 395 ITALY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 ITALY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 397 ITALY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 398 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 399 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 400 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 401 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 402 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 403 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 404 ITALY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 405 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 406 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 407 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 408 ITALY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 409 ITALY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 410 ITALY FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 411 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 413 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 414 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 415 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 416 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 417 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 418 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 419 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 420 RUSSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 421 RUSSIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 422 RUSSIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 423 RUSSIA TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 424 RUSSIA TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 425 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 426 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 427 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 428 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 429 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 430 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 431 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 432 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 433 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 434 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 435 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 436 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 437 RUSSIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 438 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 439 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 440 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 441 RUSSIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 RUSSIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 443 RUSSIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 444 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 445 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 446 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 447 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 449 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 450 RUSSIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 451 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 452 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 453 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 454 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 455 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 456 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 457 RUSSIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 458 RUSSIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 RUSSIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 RUSSIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 461 RUSSIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 462 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 464 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 465 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 466 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 467 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 468 RUSSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 469 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 470 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 471 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 472 RUSSIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 473 RUSSIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 474 RUSSIA FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 475 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 476 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 477 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 478 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 479 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 480 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 481 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 482 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 483 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 484 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 485 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 486 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 487 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 488 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 489 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 490 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 491 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 492 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 493 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 494 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 495 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 496 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 497 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 498 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 499 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 500 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 501 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 502 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 503 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 504 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 505 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 506 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 507 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 508 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 509 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 510 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 511 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 512 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 513 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 514 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 515 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 516 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 517 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 518 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 519 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 520 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 521 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 522 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 523 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 524 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 525 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 526 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 527 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 528 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 529 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 530 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 531 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 532 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 533 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 534 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 535 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 536 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 537 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 538 NETHERLANDS FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 539 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 540 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 541 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 542 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 543 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 544 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 545 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 546 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 547 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 548 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 549 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 550 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 551 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 552 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 553 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 554 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 555 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 556 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 557 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 558 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 559 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 560 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 561 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 562 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 563 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 564 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 565 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 566 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 567 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 568 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 569 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 570 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 571 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 572 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 573 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 574 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 575 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 576 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 577 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 578 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 579 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 580 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 581 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 582 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 583 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 584 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 585 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 586 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 587 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 588 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 589 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 590 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 591 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 592 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 593 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 594 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 595 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 596 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 597 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 598 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 599 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 600 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 601 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 602 SWITZERLAND FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 603 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 604 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 605 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 606 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 607 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 608 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 609 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 610 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 611 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 612 TURKEY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 613 TURKEY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 614 TURKEY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 615 TURKEY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 616 TURKEY TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 617 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 618 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 619 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 620 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 621 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 622 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 623 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 624 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 625 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 626 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 627 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 628 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 629 TURKEY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 630 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 631 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 632 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 633 TURKEY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 634 TURKEY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 635 TURKEY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 636 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 637 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 638 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 639 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 640 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 641 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 642 TURKEY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 643 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 644 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 645 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 646 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 647 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 648 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 649 TURKEY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 650 TURKEY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 651 TURKEY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 652 TURKEY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 653 TURKEY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 654 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 655 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 656 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 657 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 658 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 659 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 660 TURKEY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 661 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 662 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 663 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 664 TURKEY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 665 TURKEY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 666 TURKEY FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 667 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 668 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 669 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 670 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 671 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 672 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 673 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 674 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 675 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 676 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 677 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 678 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 679 BELGIUM TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 680 BELGIUM TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 681 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 682 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 683 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 684 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 685 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 686 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 687 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 688 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 689 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 690 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 691 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 692 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 693 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 694 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 695 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 696 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 697 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 698 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 699 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 700 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 701 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 702 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 703 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 704 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 705 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 706 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 707 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 708 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 709 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 710 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 711 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 712 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 713 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 714 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 715 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 716 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 717 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 718 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 719 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 720 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 721 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 722 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 723 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 724 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 725 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 726 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 727 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 728 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 729 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 730 BELGIUM FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 731 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 732 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 733 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 734 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 735 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 736 REST OF EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 737 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 738 SOUTH AFRICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 739 SOUTH AFRICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 740 SOUTH AFRICA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 741 SOUTH AFRICA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 742 SOUTH AFRICA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 743 SOUTH AFRICA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 744 SOUTH AFRICA TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 745 SOUTH AFRICA TRADITIONAL DIAGNOSTIC TEST (RIDT) IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 746 SOUTH AFRICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 747 SOUTH AFRICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 748 SOUTH AFRICA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 749 SOUTH AFRICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 750 SOUTH AFRICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 751 SOUTH AFRICA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 752 SOUTH AFRICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 753 SOUTH AFRICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 754 SOUTH AFRICA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 755 SOUTH AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 756 SOUTH AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 757 SOUTH AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 758 SOUTH AFRICA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 759 SOUTH AFRICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 760 SOUTH AFRICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 761 SOUTH AFRICA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 762 SOUTH AFRICA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 763 SOUTH AFRICA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 764 SOUTH AFRICA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 765 SOUTH AFRICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 766 SOUTH AFRICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 767 SOUTH AFRICA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 768 SOUTH AFRICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 769 SOUTH AFRICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 770 SOUTH AFRICA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 771 SOUTH AFRICA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 772 SOUTH AFRICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 773 SOUTH AFRICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 774 SOUTH AFRICA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 775 SOUTH AFRICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 776 SOUTH AFRICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 777 SOUTH AFRICA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 778 SOUTH AFRICA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 779 SOUTH AFRICA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 780 SOUTH AFRICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 781 SOUTH AFRICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 782 SOUTH AFRICA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 783 SOUTH AFRICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 784 SOUTH AFRICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 785 SOUTH AFRICA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 786 SOUTH AFRICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 787 SOUTH AFRICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 788 SOUTH AFRICA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 789 SOUTH AFRICA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 790 SOUTH AFRICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 791 SOUTH AFRICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 792 SOUTH AFRICA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 793 SOUTH AFRICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 794 SOUTH AFRICA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 795 SOUTH AFRICA FECAL OCCULT PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 796 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 797 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 798 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2021-2030 (USD MILLION)
TABLE 799 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 800 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CHRONIC DISEASES AND RISING PATIENT INCLINATION TOWARDS POINT-OF-CARE TESTING ARE EXPECTED TO DRIVE THE GROWTH OF THE SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET FROM 2023 TO 2030
FIGURE 12 THE GLUCOSE MONITORING PRODUCTS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET
FIGURE 14 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY APPLICATION, 2022
FIGURE 19 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2022
FIGURE 23 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 24 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2023-2030)
FIGURE 25 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 26 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PLATFORM, 2022
FIGURE 27 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PLATFORM, 2023-2030 (USD MILLION)
FIGURE 28 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PLATFORM, CAGR (2023-2030)
FIGURE 29 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 30 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY END USER, 2022
FIGURE 31 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 SOUTH AFRICA AND EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 43 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2022 (%)
FIGURE 44 SOUTH AFRICA POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
